Back to
RA CAPITAL MANAGEMENT, L.P.
CNTB
Showing 0 of 13 quarters
Position history for
RA CAPITAL MANAGEMENT, L.P.'s holdings in CONNECT BIOPHARMA HLDGS LTD
No. RA Capital Management exited its CNTB (Connect Biopharma) position in Q1 2024. Its Q4 2023 13F listed 3,062,871 shares worth $3.6M. RA Capital Management first reported CNTB in Q1 2021 and held it in 12 quarterly 13F filings.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.